Strut Health vs Breeze Meds
One seller prices the tablet below the injection; the other prices it a hundred above.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Strut Health
Partner
$99/mo
Injectable semaglutide is $149 a month, the oral $99, and tirzepatide $199 in either form. Those are auto-refill rates. Buy the oral tirzepatide once rather than on refill and it is $239, and the injection carries a $325 compare-at figure. Not sold in Alaska.
Pick it for: Buyers who want a tablet and want it to be the cheaper route
Breeze Meds
Partner
$299/mo
Injectable semaglutide is $199 a month, the oral tablet $299, and tirzepatide $399 either way. The oral is also sold as prepaid three-, six- and twelve-month blocks, and the monthly equivalent of each lands within a few dollars of just paying monthly. Fifty states.
Pick it for: Buyers who want the injection and no standing-order condition
Our verdict
Strut Health's oral semaglutide is $99 against $149 injected. Breeze Meds inverts that, at $299 oral against $199 injected. The format premium runs in opposite directions.
What actually separates them
Strut Health and Breeze Meds state different things about published price and where you can use it. Everything else they publish, they publish the same way.
Breeze Meds costs $200 more than Strut Health — 202% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,188 at Strut Health against $3,588 at Breeze Meds — a difference of $2,400.
| Strut Health | Breeze Meds | |
|---|---|---|
| Published price | $99/mo | $299/mo |
| Where you can use it | 49 states | 50 states |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.